Atamanyuk Iryna, Raja Shahzad G, Kostolny Martin
Department of Paediatric Cardiothoracic Surgery, Great Ormond Street Hospital, London, UK.
J Heart Valve Dis. 2012 Sep;21(5):682-5.
Percutaneous pulmonary valve implantation (PPVI) has revolutionized the management of right ventricular outflow tract dysfunction after repaired congenital heart disease. Although the technology is considered to be safe with a relatively low complication rate, infection is a described complication, with five cases of culture-positive infective endocarditis of percutaneously implanted pulmonary valve having been reported to date worldwide. Herein is reported the first ever case of culture-negative endocarditis following PPVI, caused by Bartonella henselae, diagnosed five years after implantation in a 15-year-old patient with a repaired truncus arteriosus.
经皮肺动脉瓣植入术（PPVI）彻底改变了先天性心脏病修复术后右心室流出道功能障碍的治疗方式。尽管该技术被认为是安全的，并发症发生率相对较低，但感染是一种已被描述的并发症，迄今为止全球已报告了5例经皮植入肺动脉瓣的血培养阳性感染性心内膜炎病例。本文报告了首例PPVI术后由汉赛巴尔通体引起的血培养阴性心内膜炎病例，该病例发生在一名15岁法洛四联症修复术后患者植入瓣膜五年后。
